Home Synpromics

Synpromics

acquired
Donation/ Crowdfunding
Gene Drug Developer
Basic
Enterprise Profile

Basic Information

Synpromics is a leader in the field of gene control, enabling safer and more effective cell and gene therapies to improve human health through proprietary genomics, bioinformatics, and intelligent data-driven design.Synpromics achieves unprecedented control of gene expression through the ability to custom-design synthetic cell-type or condition-specific promoters. We achieve this by utilizing proprietary and cutting-edge technologies, including advanced bioinformatics and screening methods.
Synpromics Ltd
Edinburgh,Scotland,United Kingdom
15~50 people
January 01, 2010
info@synpromics.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Production of Genetically Engineered Drugs
Technology
Gene Synthesis Cell Technology
Concept
Disease Treatment
Application Scenarios
Innovative Drugs